Geode Capital Management’s Artelo Biosciences ARTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $213K | Sell |
16,032
-10,730
| -40% | -$142K | ﹤0.01% | 3852 |
|
|
2025
Q1 | $23.4K | Buy |
26,762
+9,412
| +54% | +$8.24K | ﹤0.01% | 4320 |
|
|
2024
Q4 | $18.4K | Hold |
17,350
| – | – | ﹤0.01% | 4394 |
|
|
2024
Q3 | $19.8K | Sell |
17,350
-2,458
| -12% | -$2.8K | ﹤0.01% | 4395 |
|
|
2024
Q2 | $27.7K | Hold |
19,808
| – | – | ﹤0.01% | 4399 |
|
|
2024
Q1 | $29.7K | Hold |
19,808
| – | – | ﹤0.01% | 4413 |
|
|
2023
Q4 | $27.5K | Hold |
19,808
| – | – | ﹤0.01% | 4462 |
|
|
2023
Q3 | $28.9K | Buy |
19,808
+6,101
| +45% | +$8.91K | ﹤0.01% | 4547 |
|
|
2023
Q2 | $27.6K | Hold |
13,707
| – | – | ﹤0.01% | 4613 |
|
|
2023
Q1 | $31.8K | Hold |
13,707
| – | – | ﹤0.01% | 4616 |
|
|
2022
Q4 | $39K | Buy |
13,707
+1,234
| +10% | +$3.51K | ﹤0.01% | 4658 |
|
|
2022
Q3 | $43K | Sell |
12,473
-174,593
| -93% | -$602K | ﹤0.01% | 4796 |
|
|
2022
Q2 | $59K | Buy |
187,066
+19,240
| +11% | +$6.07K | ﹤0.01% | 4738 |
|
|
2022
Q1 | $75K | Buy |
167,826
+5,076
| +3% | +$2.27K | ﹤0.01% | 4730 |
|
|
2021
Q4 | $84K | Hold |
162,750
| – | – | ﹤0.01% | 4769 |
|
|
2021
Q3 | $128K | Buy |
162,750
+22,139
| +16% | +$17.4K | ﹤0.01% | 4601 |
|
|
2021
Q2 | $167K | Sell |
140,611
-662
| -0.5% | -$786 | ﹤0.01% | 4402 |
|
|
2021
Q1 | $230K | Buy |
141,273
+80,396
| +132% | +$131K | ﹤0.01% | 4070 |
|
|
2020
Q4 | $44K | Buy |
+60,877
| New | +$44K | ﹤0.01% | 4188 |
|